Chambers CR - Search Results

1

Preventing drug vial wastage and reducing expenditure associated with injectable cancer drugs: International oncology pharmacy survey.

Gilbar PJ, Chambers CR, Musicco F. Gilbar PJ, et al. Among authors: chambers cr. J Oncol Pharm Pract. 2022 Sep;28(6):1332-1339. doi: 10.1177/10781552211024723. Epub 2021 Jun 17. J Oncol Pharm Pract. 2022. PMID: 34134569

2

Antineoplastic agent workplace contamination study: the Alberta Cancer Board Pharmacy perspective.

Schulz H, Bigelow S, Dobish R, Chambers CR. Schulz H, et al. Among authors: chambers cr. J Oncol Pharm Pract. 2005 Sep;11(3):101-9. doi: 10.1191/1078155205jp152oa. J Oncol Pharm Pract. 2005. PMID: 16390598

3

The oncology impact of highly active antiretroviral therapy.

Schlichemeyer R, Chambers C, Gill MJ. Schlichemeyer R, et al. J Oncol Pharm Pract. 2007 Mar;13(1):17-25. doi: 10.1177/1078155206074045. J Oncol Pharm Pract. 2007. PMID: 17621563

4

Efficacy vs. effectiveness--docetaxel and prednisone in hormone refractory prostate cancer.

Howard DN, Chambers C, Cusano F. Howard DN, et al. J Oncol Pharm Pract. 2008 Mar;14(1):45-9. doi: 10.1177/1078155207085387. J Oncol Pharm Pract. 2008. PMID: 18337440

5

Oncology medication safety: a 3D status report 2008.

Johnson PE, Chambers CR, Vaida AJ. Johnson PE, et al. Among authors: chambers cr. J Oncol Pharm Pract. 2008 Dec;14(4):169-80. doi: 10.1177/1078155208097634. Epub 2008 Sep 25. J Oncol Pharm Pract. 2008. PMID: 18818220

6

A medication error prevention survey: five years of results.

Cusano FL, Chambers CR, Summach DL. Cusano FL, et al. Among authors: chambers cr. J Oncol Pharm Pract. 2009 Jun;15(2):87-93. doi: 10.1177/1078155208099284. Epub 2008 Nov 26. J Oncol Pharm Pract. 2009. PMID: 19036904

7

A feasibility study to assess the integration of a pharmacist into neurooncology clinic.

Delaney L, Chambers C, Roldán G, De Robles P, Cairncross G, Forsyth P, Easaw J. Delaney L, et al. J Oncol Pharm Pract. 2009 Jun;15(2):79-85. doi: 10.1177/1078155208099281. Epub 2008 Nov 26. J Oncol Pharm Pract. 2009. PMID: 19036905

8

Antineoplastic agent workplace contamination study: the Alberta Cancer Board Pharmacy perspective Phase III.

Bigelow S, Schulz H, Dobish R, Chambers CR. Bigelow S, et al. Among authors: chambers cr. J Oncol Pharm Pract. 2009 Sep;15(3):157-60. doi: 10.1177/1078155208101097. Epub 2009 Jan 26. J Oncol Pharm Pract. 2009. PMID: 19171554

9

Look-alike, sound-alike drugs in oncology.

Kovacic L, Chambers C. Kovacic L, et al. J Oncol Pharm Pract. 2011 Jun;17(2):104-18. doi: 10.1177/1078155209354135. Epub 2010 Jan 29. J Oncol Pharm Pract. 2011. PMID: 20118216

10

Optimizing pain relief in a specialized outpatient palliative radiotherapy clinic: contributions of a clinical pharmacist.

Gagnon L, Fairchild A, Pituskin E, Dutka J, Chambers C. Gagnon L, et al. J Oncol Pharm Pract. 2012 Mar;18(1):76-83. doi: 10.1177/1078155211402104. Epub 2011 Apr 13. J Oncol Pharm Pract. 2012. PMID: 21490115

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page